These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 9840682)
1. Inhibition of experimental autoimmune neuritis by the immunomodulator linomide. Karpati T; Karussis D; Abramsky O; Mizrahi-Koll R; Arbell I; Ovadia H Immunol Lett; 1998 Oct; 63(3):141-5. PubMed ID: 9840682 [TBL] [Abstract][Full Text] [Related]
2. Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses. Zhu J; Bai XF; Hedlund G; Björk J; Bakhiet M; Van Der Meide PH; Link H Clin Exp Immunol; 1999 Jan; 115(1):56-63. PubMed ID: 9933420 [TBL] [Abstract][Full Text] [Related]
3. Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions. Bai XF; Shi FD; Zhu J; Xiao BG; Hedlund G; Link H J Neuroimmunol; 1997 Jun; 76(1-2):177-84. PubMed ID: 9184648 [TBL] [Abstract][Full Text] [Related]
4. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81. Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221 [TBL] [Abstract][Full Text] [Related]
5. Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue. Zou LP; Abbas N; Volkmann I; Nennesmo I; Levi M; Wahren B; Winblad B; Hedlund G; Zhu J Neuropharmacology; 2002 Apr; 42(5):731-9. PubMed ID: 11985832 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1. Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363 [TBL] [Abstract][Full Text] [Related]
7. Adoptive transfer-experimental allergic neuritis in newborn Lewis rats results in inflammatory infiltrates, mast cell activation, and increased Ia expression with only minor nerve fiber degeneration. Pilartz M; Jess T; Indefrei D; Schröder JM Acta Neuropathol; 2002 Nov; 104(5):513-24. PubMed ID: 12410399 [TBL] [Abstract][Full Text] [Related]
8. Pain hypersensitivity in rats with experimental autoimmune neuritis, an animal model of human inflammatory demyelinating neuropathy. Moalem-Taylor G; Allbutt HN; Iordanova MD; Tracey DJ Brain Behav Immun; 2007 Jul; 21(5):699-710. PubMed ID: 17005365 [TBL] [Abstract][Full Text] [Related]
9. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens. Zhu J; Zou LP; Bakhiet M; Mix E J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142 [TBL] [Abstract][Full Text] [Related]
10. Modulation of experimental autoimmune neuritis in Lewis rats by oral application of myelin antigens. Gaupp S; Hartung HP; Toyka K; Jung S J Neuroimmunol; 1997 Nov; 79(2):129-37. PubMed ID: 9394785 [TBL] [Abstract][Full Text] [Related]
11. Time Course of Axon and Myelin Degeneration in Peripheral Nerves in Experimental Autoimmune Neuritis Rats. Tomikawa E; Mutsuga M; Hara K; Kaneko C; Togashi Y; Miyamoto Y Toxicol Pathol; 2019 Jun; 47(4):542-552. PubMed ID: 30987532 [TBL] [Abstract][Full Text] [Related]
12. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. Zou LP; Pelidou SH; Abbas N; Deretzi G; Mix E; Schaltzbeerg M; Winblad B; Zhu J J Neuroimmunol; 1999 Aug; 98(2):168-75. PubMed ID: 10430050 [TBL] [Abstract][Full Text] [Related]
13. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role. Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455 [TBL] [Abstract][Full Text] [Related]
14. Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope. Stienekemeier M; Falk K; Rötzschke O; Weishaupt A; Schneider C; Toyka KV; Gold R; Strominger JL Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13872-7. PubMed ID: 11717443 [TBL] [Abstract][Full Text] [Related]
16. The effect of treatment with crotapotin on the evolution of experimental autoimmune neuritis induced in Lewis rats. Castro FR; Farias AS; Proença PL; de La Hoz C; Langone F; Oliveira EC; Toyama MH; Marangoni S; Santos LM Toxicon; 2007 Mar; 49(3):299-305. PubMed ID: 17145071 [TBL] [Abstract][Full Text] [Related]
17. Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies. Schmidt J; Elflein K; Stienekemeier M; Rodriguez-Palmero M; Schneider C; Toyka KV; Gold R; Hünig T J Neuroimmunol; 2003 Jul; 140(1-2):143-52. PubMed ID: 12864982 [TBL] [Abstract][Full Text] [Related]
18. Antigen-specific immunosuppression: nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats. Zou LP; Ma DH; Levi M; Wahren B; Wei L; Mix E; van der Meide PH; Link H; Zhu J J Neuroimmunol; 1999 Feb; 94(1-2):109-21. PubMed ID: 10376943 [TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental allergic neuritis by an antibody to the intracellular adhesion molecule ICAM-1. Archelos JJ; Mäurer M; Jung S; Toyka KV; Hartung HP Brain; 1993 Oct; 116 ( Pt 5)():1043-58. PubMed ID: 7693297 [TBL] [Abstract][Full Text] [Related]
20. Differential susceptibility to experimental autoimmune neuritis in Lewis rat strains is associated with T-cell immunity to myelin antigens. Zhu W; Zhang K; Mix E; Wang X; Adem A; Zhu J J Neurosci Res; 2011 Mar; 89(3):448-56. PubMed ID: 21259331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]